263 related articles for article (PubMed ID: 17409768)
1. Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia.
Hirokoshi K; Maeshima Y; Kobayashi K; Matsuura E; Sugiyama H; Yamasaki Y; Masuyama H; Hiramatsu Y; Makino H
Nephron Clin Pract; 2007; 106(1):c43-50. PubMed ID: 17409768
[TBL] [Abstract][Full Text] [Related]
2. Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia.
Hirokoshi K; Maeshima Y; Kobayashi K; Matsuura E; Sugiyama H; Yamasaki Y; Masuyama H; Hiramatsu Y; Makino H
Am J Hypertens; 2005 Sep; 18(9 Pt 1):1181-8. PubMed ID: 16182107
[TBL] [Abstract][Full Text] [Related]
3. Plasma markers of angiogenesis in pregnancy induced hypertension.
Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY
Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
[TBL] [Abstract][Full Text] [Related]
4. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
Ye YH; Liu L; Zhan Y; Peng W
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
[TBL] [Abstract][Full Text] [Related]
5. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
[TBL] [Abstract][Full Text] [Related]
6. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
[TBL] [Abstract][Full Text] [Related]
7. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
Chen Q; Zhao Y; Zou L; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
Ye YH; Liu L; Zhan Y; Peng W
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
[TBL] [Abstract][Full Text] [Related]
9. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.
Krysiak O; Bretschneider A; Zhong E; Webb J; Hopp H; Verlohren S; Fuhr N; Lanowska M; Nonnenmacher A; Vetter R; Jankowski J; Paul M; Schönfelder G
Circ Res; 2005 Dec; 97(12):1253-61. PubMed ID: 16269656
[TBL] [Abstract][Full Text] [Related]
10. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop.
McKeeman GC; Ardill JE; Caldwell CM; Hunter AJ; McClure N
Am J Obstet Gynecol; 2004 Oct; 191(4):1240-6. PubMed ID: 15507947
[TBL] [Abstract][Full Text] [Related]
11. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.
Verlohren S; Galindo A; Schlembach D; Zeisler H; Herraiz I; Moertl MG; Pape J; Dudenhausen JW; Denk B; Stepan H
Am J Obstet Gynecol; 2010 Feb; 202(2):161.e1-161.e11. PubMed ID: 19850276
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia.
Powers RW; Roberts JM; Cooper KM; Gallaher MJ; Frank MP; Harger GF; Ness RB
Am J Obstet Gynecol; 2005 Jul; 193(1):185-91. PubMed ID: 16021077
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of leukocyte functional antigen-3 in pregnancy and preeclampsia.
Hefler L; Kainz C; Zeisler H; Heinze G; Schatten C; Husslein P; Leodolter S; Tempfer C
Acta Obstet Gynecol Scand; 1999 Aug; 78(7):580-5. PubMed ID: 10422903
[TBL] [Abstract][Full Text] [Related]
14. [Alteration and potential role of soluble fms-like tyrosine kinase receptor 1 in preeclampsia].
Li Y; Li DH; Yao YQ; Min BH; Zhang CL; Hou XH; Huang L; Zhao HX
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):581-4. PubMed ID: 16202309
[TBL] [Abstract][Full Text] [Related]
15. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients.
Verlohren S; Herraiz I; Lapaire O; Schlembach D; Moertl M; Zeisler H; Calda P; Holzgreve W; Galindo A; Engels T; Denk B; Stepan H
Am J Obstet Gynecol; 2012 Jan; 206(1):58.e1-8. PubMed ID: 22000672
[TBL] [Abstract][Full Text] [Related]
16. Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia.
Molvarec A; Szarka A; Walentin S; Beko G; Karádi I; Prohászka Z; Rigó J
Clin Chim Acta; 2011 Oct; 412(21-22):1957-62. PubMed ID: 21756887
[TBL] [Abstract][Full Text] [Related]
17. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
[TBL] [Abstract][Full Text] [Related]
18. [Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience].
Stepan H; Schaarschmidt W; Jank A; Verlohren S; Kratzsch J
Z Geburtshilfe Neonatol; 2010 Dec; 214(6):234-8. PubMed ID: 21207323
[TBL] [Abstract][Full Text] [Related]
19. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.
Chaiworapongsa T; Romero R; Kim YM; Kim GJ; Kim MR; Espinoza J; Bujold E; Gonçalves L; Gomez R; Edwin S; Mazor M
J Matern Fetal Neonatal Med; 2005 Jan; 17(1):3-18. PubMed ID: 15804781
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
Leinonen E; Wathén KA; Alfthan H; Ylikorkala O; Andersson S; Stenman UH; Vuorela P
J Clin Endocrinol Metab; 2010 Jan; 95(1):126-33. PubMed ID: 19875484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
